AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Marksans Pharma Ltd. Capital/Financing Update 2025

Sep 24, 2025

62142_rns_2025-09-24_c5f6ac1a-5352-423e-a212-6ebff1398dcb.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [205 x 69] intentionally omitted <==

September 24, 2025

BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block - G Dalal Street Bandra-Kurla Complex Mumbai – 400001 Bandra (East), Mumbai - 400051 Scrip Code: 524404 Symbol: MARKSANS

Sub: Intimation of Grant of stock options under ‘Marksans Employees Stock Option Scheme 2024’

(“Scheme”)

Ref: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)

Dear Sir/Madam,

This is to inform you that pursuant to the special resolutions passed by the shareholders of the Company at their AGM held on September 24, 2024 & August 8, 2025 and the in-principle approval granted by the BSE Limited and National Stock Exchange of India Limited on September 17, 2025 & September 18, 2025, respectively, the Nomination and Remuneration Committee (the designated Compensation Committee) of the Company has, today i.e., September 24, 2025, approved grant of 4,00,000 (Four Lakh) Stock Options to the certain eligible employees of the Company and its subsidiaries under Marksans Employees Stock Option Scheme 2024.

The disclosure as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular Bearing Ref. No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated 13th July, 2023 with respect to the ESOP is enclosed herewith as AnnexureA .

Kindly take the above information on record.

S. NO.	DISCLOSURES	PARTICULARS
Name of the Scheme		Marksans Employees Stock Option Scheme 2024(“Scheme”)
A	Brief details of options granted	4,00,000 (Four Lakh) Stock Options have been granted to the certain eligible employees identified by the Nomination and Remuneration Committee under the Scheme. Date ofgrant is 24thSeptember 2025.
B	Whether the scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations,2021(if applicable)	Yes, the Scheme is in compliance with the provisions of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
C	Total number of shares covered bythese options	4,00,000 equity shares of face value of Re. 1/- each fully paid-up.
D	Pricingformula	The exerciseprice is Rs. 10/-(Rupees Ten only) per stock option.
E	Options vested	Not Applicable at this stage
F	Time within which option may be exercised	The exercise period for vested Options shall be of Two (2) years from the date ofgrant.
G	Options exercised	Not Applicable at this stage
H	Money realized by exercise of options	Not Applicable at this stage
I	The total number of shares arising as a result of exercise of option	Not Applicable at this stage
J	Options lapsed	Not Applicable at this stage
K	Variation of terms of options	Not Applicable at this stage
L	Brief details of significant terms	1. The vesting period for granted Options shall be One (1) year from the date of grant. 2. The granted Options, once vested, shall entitle the Option grantee to acquire equal number of equity shares, upon payment of full exercise price and applicable taxes in accordance with terms and conditions of the Scheme.
M	Subsequent changes or cancellation or exercise of such options	Not Applicable at this stage
N	Diluted earnings per share pursuant to issue of equity shares on exercise of options	Not Applicable at this stage

AI assistant

Marksans Pharma Ltd. Capital/Financing Update 2025

62142_rns_2025-09-24_c5f6ac1a-5352-423e-a212-6ebff1398dcb.pdf

Ref: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)

For Marksans Pharma Limited

H PANIGRAHI